• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用“EsophyX Z®”设备进行经口无切口胃底折叠术(TIF 2.0)治疗胃食管反流病(GERD):腔内胃底折叠术后七年。世界首例病例报告。

Transoral Incisionless Fundoplication TIF 2.0 with "EsophyX Z®" Device for GERD: Seven Years after Endo Lumenal Fundoplication. World’s First Case Report.

作者信息

Nicolau Alexandru Eugen, Lobonţiu Adrian

出版信息

Chirurgia (Bucur). 2018 Nov-Dec;113(6):849-856. doi: 10.21614/chirurgia.113.6.849.

DOI:10.21614/chirurgia.113.6.849
PMID:30596372
Abstract

Transoral Incisionless Fundoplication (TIF) with EsophyX device for a well selected GERD patient population has proven its efficacy, safety and durability. We present a case report of a male, 63 y old, with typical and atypical GERD symptoms started 15 years ago. The esophagogastroduodenoscopy (EGD) showed a Hiatal Hernia (HH) of 3 cm and an erosive esophagitis Los Angeles Grade B. The first surgery was performed 7 years ago, in March 2009: a TIF with the EsophyX 2® device (EndoGastric Solution, Inc., Redmond, WA, United States). Post-surgery the symptoms were controlled, completely eliminated, the EGD showing the healing of the esophagitis. Six years after the surgery the sore throat re-appears, while the EGD shows a 2 cm hiatal hernia and erosive esophagitis Los Angeles Grade A. The Impedance pH-metry confirms GERD with a DeMeester score of 44.5. In 2016 (7 years after first procedure) a second and new TIF 2.0 procedure, this time with EsophyX Z device is performed. The EsophyX Z device is an automatic stapler-like fastener delivery system, easier of use, faster, safer and more reproducible (standardized fastener delivery). The time of the procedure was significantly reduced, compared to first procedure. The patient is now symptom free, EGD is normal, the impendance ph metry at 13 months post-surgery showed a normal DeMeester score at 8. This is a World’s first case report of a TIF 2.0 procedure with EsophyX Z device 7 years after a first TIF procedure with EsophyX 2 device, with excellent results and a significant reduction of the time for the procedure.

摘要

对于精心挑选的胃食管反流病(GERD)患者群体,使用EsophyX设备进行经口无切口胃底折叠术(TIF)已证明其有效性、安全性和持久性。我们报告一例63岁男性病例,其15年前开始出现典型和非典型GERD症状。食管胃十二指肠镜检查(EGD)显示有3厘米的食管裂孔疝(HH)和洛杉矶分级B级糜烂性食管炎。首次手术于7年前,即2009年3月进行:使用EsophyX 2®设备(美国华盛顿州雷德蒙德市的EndoGastric Solution公司)进行TIF。手术后症状得到控制,完全消除,EGD显示食管炎愈合。手术后6年,喉咙痛再次出现,而EGD显示有2厘米的食管裂孔疝和洛杉矶分级A级糜烂性食管炎。阻抗pH测量证实为GERD,DeMeester评分为44.5。2016年(首次手术后7年)进行了第二次新的TIF 2.0手术,这次使用的是EsophyX Z设备。EsophyX Z设备是一种类似自动订书机的紧固件输送系统,使用更方便、速度更快、更安全且更可重复(标准化的紧固件输送)。与首次手术相比,手术时间显著缩短。患者现在无症状,EGD正常,术后13个月的阻抗pH测量显示DeMeester评分为8,结果正常。这是世界上首例在首次使用EsophyX 2设备进行TIF手术后7年,使用EsophyX Z设备进行TIF 2.0手术的病例报告,结果极佳,手术时间显著缩短。

相似文献

1
Transoral Incisionless Fundoplication TIF 2.0 with "EsophyX Z®" Device for GERD: Seven Years after Endo Lumenal Fundoplication. World’s First Case Report.使用“EsophyX Z®”设备进行经口无切口胃底折叠术(TIF 2.0)治疗胃食管反流病(GERD):腔内胃底折叠术后七年。世界首例病例报告。
Chirurgia (Bucur). 2018 Nov-Dec;113(6):849-856. doi: 10.21614/chirurgia.113.6.849.
2
Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.使用Esophyx装置经口无切口胃底折叠术治疗对药物治疗有反应的胃食管反流病的长期益处。
Dis Esophagus. 2017 Feb 1;30(3):1-8. doi: 10.1111/dote.12525.
3
Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.腹腔镜食管裂孔疝修补术联合使用EsophyX装置的经口无切口胃底折叠术(HH + TIF):两家社区医院的疗效与安全性
Surg Innov. 2019 Dec;26(6):675-686. doi: 10.1177/1553350619869449. Epub 2019 Aug 20.
4
Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.经口无切口胃底折叠术(TIF 2.0)联合 EsophyX 治疗胃食管反流病:长期结果及影响结局的发现。
Surg Endosc. 2012 May;26(5):1425-35. doi: 10.1007/s00464-011-2050-1. Epub 2011 Dec 15.
5
Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.使用Esophyx(Tif 2.0)经口无切口胃底折叠术的长期疗效及影响胃食管反流病患者长达6年随访结果的因素:一项前瞻性单中心研究
Surg Endosc. 2015 Sep;29(9):2770-80. doi: 10.1007/s00464-014-4008-6. Epub 2014 Dec 6.
6
Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.使用EsophyX进行的抗反流经口无切口胃底折叠术:一项前瞻性多中心研究的12个月结果。
World J Surg. 2008 Aug;32(8):1676-88. doi: 10.1007/s00268-008-9594-9.
7
Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease.经口无切口胃底折叠术治疗慢性胃食管反流病合并或不合并食管裂孔疝的短期安全性和症状结果。
Am J Surg. 2011 Dec;202(6):740-6; discussion 746-7. doi: 10.1016/j.amjsurg.2011.06.035. Epub 2011 Oct 20.
8
Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease.经口内镜下食管胃底折叠术治疗胃食管反流病的临床和 pH 计量学结果。
Surg Endosc. 2011 Jun;25(6):1975-84. doi: 10.1007/s00464-010-1497-9. Epub 2010 Dec 8.
9
Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.经口胃底折叠术可为慢性胃食管反流病提供持久的症状控制:来自有交叉臂的TEMPO随机试验的3年报告。
Surg Endosc. 2017 Jun;31(6):2498-2508. doi: 10.1007/s00464-016-5252-8. Epub 2016 Sep 21.
10
Transoral incisionless fundoplication for recurrent symptoms after laparoscopic fundoplication.经口无切口胃底折叠术治疗腹腔镜胃底折叠术后复发症状。
Surg Endosc. 2023 May;37(5):3701-3709. doi: 10.1007/s00464-023-09880-4. Epub 2023 Jan 17.